Leo Pharma Investigational Site

Markham, Ontario L3P 1X3

1 studies enrolling now · 6 studies all time

What they study most

Atopic Dermatitis, Palmoplantar Pustulosis

Studies at this site

• A 16-week Trial to Investigate the Efficacy and Safety of Delgocitinib Cream 20 mg/g in Adult Participants With Mild to Severe Palmoplantar Pustulosis — Recruiting now
• An Evaluation of LEO 138559 in Adults With Moderate to Severe Atopic Dermatitis. — Completed
• Dose-ranging Trial to Evaluate Delgocitinib Cream 1, 3, 8, and 20 mg/g Compared to Delgocitinib Cream Vehicle Over an 8-week Treatment Period in Adult Subjects With Atopic Dermatitis. — Completed
• Tralokinumab Monotherapy for Adolescent Subjects With Moderate to Severe Atopic Dermatitis - ECZTRA 6 (ECZema TRAlokinumab Trial no. 6). — Completed
• Long-term Extension Trial in Subjects With Atopic Dermatitis Who Participated in Previous Tralokinumab Trials - ECZTEND — Completed
• Efficacy and Safety of LEO 152020 Tablets for the Treatment of Adults With Moderate to Severe Atopic Dermatitis — Completed